Skip to main content
. 2021 Nov 1;8:1311–1322. doi: 10.2147/JHC.S338456

Table 1.

The Baseline Patient Characteristics Among Four Institutions

Characteristics Overall (n=231) Institution A (n=71) Institution B (n=74) Institution C (n=45) Institution D (n=41) P
Age (years) 56.2±11.6 58.8±11.5 55.3±11.0 54.0±11.0 55.7±14.8 0.083
Sex (%) 0.024
 Male 205 (88.7%) 65 (91.5%) 59 (79.7%) 41 (91.1%) 40 (97.6%)
 Female 26 (11.3%) 6 (8.5%) 15 (20.3%) 4 (7.9%) 1 (2.4%)
Number of tumors (%) <0.001
 Single 113 (48.9%) 36 (50.7%) 32 (43.2%) 26 (57.8%) 19 (46.3%)
 Multiple 118 (51.1%) 35 (49.3%) 42 (56.8%) 19 (42.2%) 22 (53.7%)
Albumin (g/L, median with IQR) 56.2±11.6 36.5±4.6 38.8±5.3 39.7±4.3 38.5±6.0 0.169
Total bilirubin (umol/L, median with IQR) 15.3 (11.6) 15.6 (13.4) 15.9 (8.0) 14.9 (7.5) 15.5 (13.4) 0.830
Platelet (×109, median with IQR) 155.0 (103.0) 143.0 (107.0) 155.0 (108.75) 176.0 (106.5) 140.0 (120.0) 0.051
Child-Pugh class (%) 0.088
 A 214 (92.6%) 66 (93.0%) 67 (90.5%) 45 (100%) 36 (87.8%)
 B 17 (7.4%) 5 (7.0%) 7 (9.5%) 0 5 (12.2%)
Etiologies of cirrhosis (%) 0.038
 None 27 (11.7%) 12 (16.9%) 5 (6.8%) 1 (2.2%) 9 (22.0%)
 HBV 188 (81.4%) 54 (76.1%) 64 (86.5%) 41 (91.1%) 29 (70.7%)
 HCV 7 (3.0%) 3 (4.2%) 2 (2.7%) 0 2 (4.9%)
 Alcohol 3 (1.3%) 0 2 (2.7%) 1 (2.2%) 0
 Cryptogenic 6 (2.6%) 2 (2.8%) 1 (1.4%) 3 (1.3%) 1 (2.4%)
Tumor distribution (%) 0.584
 Unilobar 148 (64.1%) 43 (60.6%) 52 (70.3%) 27 (60.0%) 26 (63.4%)
 Bilobar 83 (35.9%) 28 (39.4%) 22 (29.7%) 18 (40.0%) 15 (36.6%)
AFP (%) 0.134
 ≤400 ng/mL 142 (61.5%) 40 (56.3%) 52 (70.3%) 23 (51.1%) 27 (65.9%)
 >400 ng/mL 89 (38.5%) 31 (43.7%) 22 (29.7%) 22 (48.9%) 14 (34.1%)
The largest tumor size (mm, median with IQR) 75.0 (48.8) 74.0 (56.0) 63.0 (41.5) 102.0 (67.1) 84.9 (43.6) <0.001

Abbreviations: IQR, inter-quartile range; AFP, alpha fetoprotein.